S
Shinsei Capital Partners
Tokyo
Overview
Shinsei Capital Partners is a Japanese venture capital firm, carved out from the Shinsei Bank Group, that specializes in investing in life science companies including drug discovery and digital health.
Year Founded
2018
Portfolio Companies
13
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| AlphaNavi Pharma Inc. | Mar 2023 | Series B | Co-investor |
| Ubie | Jul 2022 | Series C | - |
| Metcela Inc. | Jun 2022 | Series C | - |
| LUCA Science | Jun 2022 | Series B | - |
| Luxna Biotech Co., Ltd. | Dec 2021 | Debt | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
